Ensign Peak Advisors, Inc Tandem Diabetes Care Inc Transaction History

Ensign Peak Advisors, Inc

$58.8 Billion
Q3 2025

A detailed history of Ensign Peak Advisors, Inc transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 17,182 shares of TNDM stock, worth $319,757. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,182

Previous 25,532 32.7%

Holding current value

$319,757

Previous $489,000 57.46%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$10.12 - $17.24 $84,502 - $143,954	-8,350 Reduced 32.7%	17,182 $208,000
Q1 2024 May 14, 2024	SELL	$22.09 - $35.41 $28,451 - $45,608	-1,288 Reduced 4.8%	25,532 $904,000
Q4 2023 Feb 14, 2024	BUY	$14.28 - $31.03 $59,976 - $130,326	4,200 Added 18.57%	26,820 $793,000
Q1 2023 May 15, 2023	BUY	$35.86 - $46.5 $1,793 - $2,325	50 Added 0.22%	22,620 $918,000
Q4 2022 Feb 13, 2023	BUY	$35.49 - $56.15 $209,391 - $331,285	5,900 Added 35.39%	22,570 $1.01 Million

Q2 2022 Aug 12, 2022	BUY	$53.22 - $123.09 $89,941 - $208,022	1,690 Added 11.28%	16,670 $987,000
Q4 2021 Feb 11, 2022	BUY	$118.18 - $153.21 $245,814 - $318,676	2,080 Added 16.12%	14,980 $2.26 Million
Q3 2021 Nov 12, 2021	BUY	$93.51 - $129.4 $1.21 Million - $1.67 Million	12,900 New	12,900 $1.53 Million
Q1 2021 May 12, 2021	SELL	$81.28 - $104.34 $217,749 - $279,526	-2,679 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$86.4 - $121.75 $49,766 - $70,128	576 Added 27.39%	2,679 $256,000
Q3 2020 Nov 12, 2020	SELL	$95.43 - $116.09 $45,997 - $55,955	-482 Reduced 18.65%	2,103 $239,000
Q1 2020 May 11, 2020	BUY	$47.37 - $90.04 $122,451 - $232,753	2,585 New	2,585 $166,000

Others Institutions Holding TNDM

# of Institutions

289

Shares Held

74.1M

Call Options Held

2.94M

Put Options Held

362K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.2B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Tandem Diabetes Care Inc Transaction History